These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3053887)

  • 21. Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.
    Morgan MY
    Metab Brain Dis; 2016 Dec; 31(6):1361-1364. PubMed ID: 27638474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lactitol, a second-generation disaccharide for treatment of chronic portal-systemic encephalopathy. A double-blind, crossover, randomized clinical trial.
    Uribe M; Toledo H; Perez F; Vargas F; Gil S; Garcia-Ramos G; Ravelli GP; Guevara L
    Dig Dis Sci; 1987 Dec; 32(12):1345-53. PubMed ID: 3319453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lactulose and its derivatives--treatment of hepatic encephalopathy and other possible indications for its use].
    Fehér J; Prónai L
    Orv Hetil; 1993 Jun; 134(26):1417-9. PubMed ID: 8332363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
    Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
    Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.
    Atterbury CE; Maddrey WC; Conn HO
    Am J Dig Dis; 1978 May; 23(5):398-406. PubMed ID: 354373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study.
    Loguercio C; Del Vecchio Blanco C; Coltorti M
    J Int Med Res; 1987; 15(6):335-43. PubMed ID: 3125077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.
    Mas A; Rodés J; Sunyer L; Rodrigo L; Planas R; Vargas V; Castells L; Rodríguez-Martínez D; Fernández-Rodríguez C; Coll I; Pardo A;
    J Hepatol; 2003 Jan; 38(1):51-8. PubMed ID: 12480560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of lactitol on blood ammonia response to oral glutamine challenge in cirrhotic patients: evidence for an effect of nonabsorbable disaccharides on small intestine ammonia generation.
    Masini A; Efrati C; Merli M; Attili AF; Amodio P; Ceccanti M; Riggio O
    Am J Gastroenterol; 1999 Nov; 94(11):3323-7. PubMed ID: 10566738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy.
    Tarao K; Ikeda T; Hayashi K; Sakurai A; Okada T; Ito T; Karube H; Nomoto T; Mizuno T; Shindo K
    Gut; 1990 Jun; 31(6):702-6. PubMed ID: 2199349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of the laxative effect of Lactitol as opposed to lactulose in an open, randomized comparative study].
    Heitland W; Mauersberger H
    Schweiz Rundsch Med Prax; 1988 May; 77(18):493-5. PubMed ID: 3051260
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients.
    Riggio O; Varriale M; Testore GP; Di Rosa R; Di Rosa E; Merli M; Romiti A; Candiani C; Capocaccia L
    J Clin Gastroenterol; 1990 Aug; 12(4):433-6. PubMed ID: 2398251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapy for hepatic encephalopathy.
    Phongsamran PV; Kim JW; Cupo Abbott J; Rosenblatt A
    Drugs; 2010 Jun; 70(9):1131-48. PubMed ID: 20518580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy.
    Horsmans Y; Solbreux PM; Daenens C; Desager JP; Geubel AP
    Aliment Pharmacol Ther; 1997 Feb; 11(1):165-70. PubMed ID: 9042989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial effect of carbohydrate maldigestion induced by a disaccharidase inhibitor (AO-128) in the treatment of chronic portal-systemic encephalopathy. A double-blind, randomized, controlled trial.
    Uribe M; Morán S; Poo JL; Méndez-Sánchez N; Guevara L; García-Ramos G
    Scand J Gastroenterol; 1998 Oct; 33(10):1099-106. PubMed ID: 9829367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.
    Als-Nielsen B; Gluud LL; Gluud C
    BMJ; 2004 May; 328(7447):1046. PubMed ID: 15054035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lactitol or lactulose in the treatment of chronic constipation: result of a systematic.
    Maydeo A
    J Indian Med Assoc; 2010 Nov; 108(11):789-92. PubMed ID: 21510584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
    Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
    Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
    [No Abstract]   [Full Text] [Related]  

  • 38. Lactitol.
    Lancet; 1987 Jul; 2(8550):81-2. PubMed ID: 2885579
    [No Abstract]   [Full Text] [Related]  

  • 39. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Puri V; Sachdeva S; Srivastava S
    Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study.
    Poo JL; Góngora J; Sánchez-Avila F; Aguilar-Castillo S; García-Ramos G; Fernández-Zertuche M; Rodríguez-Fragoso L; Uribe M
    Ann Hepatol; 2006; 5(4):281-8. PubMed ID: 17151582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.